Your session is about to expire
← Back to Search
Brachytherapy
Hydrogel Packing System for Cervical Cancer
N/A
Waitlist Available
Led By Kara Romano
Research Sponsored by University of Virginia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
FIGO IB1 - IVB Staging according to FIGO and TNM guidelines
Karnofsky performance status (KPS) ≥ 70 or ECOG status ≤1
Must not have
Plan to receive external beam RT (EBRT) alone as the definitive treatment plan for the cancer of interest
Known contraindications to brachytherapy
Timeline
Screening 3 weeks
Treatment Varies
Follow Up fractions/radiation treatments 2 - 5: about 1-4 weeks after starting brachytherapy
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing a new, low cost packing system for brachytherapy to see if it is as effective as the standard options, and to understand any associated discomfort and safety concerns.
Who is the study for?
This trial is for adults over 18 with cervical cancer who are planning to receive brachytherapy. They must have a performance status indicating they can carry out daily activities and agree to lifestyle considerations during the study. Those with prior pelvic radiation, hysterectomy, or pregnant/lactating individuals cannot participate.
What is being tested?
The study compares a new low-cost packing system called 'BrachyGel VHPS' against standard options used in high-dose-rate (HDR) brachytherapy for cervical cancer. It aims to ensure BrachyGel VHPS protects nearby organs from radiation effectively and assesses patient safety and comfort.
What are the potential side effects?
While specific side effects of BrachyGel VHPS aren't detailed, potential risks may include discomfort at the application site, possible allergic reactions to materials in the hydrogel, and typical brachytherapy-related side effects like localized pain or bleeding.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My cervical cancer is between stages IB1 and IVB.
Select...
I am mostly able to care for myself and carry out daily activities.
Select...
I am planning to undergo brachytherapy for my cervical cancer treatment.
Select...
My biopsy shows I have cervical cancer.
Select...
I am 18 years old or older.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am scheduled for external beam radiation therapy as my main cancer treatment.
Select...
I cannot have brachytherapy due to health reasons.
Select...
I have had a hysterectomy.
Select...
I have had radiation therapy in my pelvis or abdomen not related to my current cancer treatment.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ fractions/radiation treatments 2 - 5: about 1-4 weeks after starting brachytherapy
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~fractions/radiation treatments 2 - 5: about 1-4 weeks after starting brachytherapy
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Highest dose of radiation (in Gy) to the rectum and bladder for each patient
Secondary study objectives
Adverse Events
Highest dose of radiation (in Gy) to the rectum and bladder for each patient at each treatment
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Arm B: BrachyGel in fractions 2 and 4Experimental Treatment1 Intervention
BrachyGel VHPS in fractions 2 and 4 and standard packing in fractions 3 and 5
Group II: Arm A: BrachyGel in fractions 3 and 5Experimental Treatment1 Intervention
BrachyGel VHPS in fractions 3 and 5 and standard packing in fractions 2 and 4
Find a Location
Who is running the clinical trial?
University of VirginiaLead Sponsor
782 Previous Clinical Trials
1,315,681 Total Patients Enrolled
BrachyFoam, LLCUNKNOWN
Kara RomanoPrincipal Investigator - University of Virginia
University of Virginia
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am scheduled for external beam radiation therapy as my main cancer treatment.My cervical cancer is between stages IB1 and IVB.I cannot have brachytherapy due to health reasons.I am mostly able to care for myself and carry out daily activities.I am planning to undergo brachytherapy for my cervical cancer treatment.My biopsy shows I have cervical cancer.I am 18 years old or older.I have had a hysterectomy.I have had radiation therapy in my pelvis or abdomen not related to my current cancer treatment.
Research Study Groups:
This trial has the following groups:- Group 1: Arm B: BrachyGel in fractions 2 and 4
- Group 2: Arm A: BrachyGel in fractions 3 and 5
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.